bioAffinity Technologies, Inc.
No trades
Fundamentals and stats
EPS and revenue snapshot
In the last quarter, the company reported -4.74 USD per share, beating the -2.70 USD estimate by -75.56%. Revenue for the same period reached 1.45 M USD, despite the estimate of 1.41 M USD. For the next quarter, analysts expect -2.70 USD in earnings per share and 1.55 M USD in revenue.
Next report date—
Report period—
EPS estimate—
Revenue estimate—
EPS
Reported
Estimate
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Reported
Estimate
Surprise